Concepedia

Olivier J. David

OJ

6

Publications

363

Citations

6

H-Index

2000

Active since

Affiliations

Novartis (Switzerland)(Current)

Olivier J. David is an author at Novartis (Switzerland) specializing in medicine, pharmacokinetics, and drug absorption.

Top concepts

Publications per year

2000–2022

6

Publications

6

The <scp>BACE</scp> ‐1 inhibitor <scp>CNP</scp> 520 for prevention trials in Alzheimer's disease

Ulf Neumann, Mike Ufer, Laura H. Jacobson et al. · EMBO Molecular Medicine · 2018 · 167 citations · Full text

Pharmacokinetic validation of neoral absorption profiling

A. E. Johnston, Olivier J. David, Gerard F. Cooney · Transplantation Proceedings · 2000 · 95 citations

, , +4

Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis

Huixin Yu, Gordon Graham, Olivier J. David et al. · CNS Drugs · 2022 · 35 citations · Full text

Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC0–12 monitoring in cardiac transplant recipients over the first year post-transplantation

Caroline Monchaud, Annick Rousseau, F. Léger et al. · European Journal of Clinical Pharmacology · 2003 · 34 citations

, , +6

Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery

Nicholas R. Banner, Olivier J. David, Neil Leaver et al. · Transplant International · 2002 · 18 citations

Rows per page

1–5 of 6